[1] |
胡治勇, 崔龙, 董晓颖, 等. 糖尿病患者骨质疏松评估、危险因素及相关机制的研究进展[J]. 重庆医学, 2020, 49(4):660-664. doi: 10.3969/j.issn.1671-8348.2020.04.033 |
[2] |
ALAM, JAFARIRM, DEHPOURAR. Diabetes mellitus and osteoporosis correlation: challenges and hopes[J]. Curr Diabetes Rev,2020,16(9):984-1001. doi: 10.2174/1573399816666200324152517 |
[3] |
吕茵, 周围, 何文娜, 等. 2型糖尿病合并骨质疏松影响因素研究[J]. 新医学, 2020, 51(1):33-36. doi: 10.3969/j.issn.0253-9802.2020.01.007 |
[4] |
黄燕霞, 梅思. 糖尿病性骨质疏松的研究进展[J]. 临床与病理杂志, 2020, 40(1):182-187. doi: 10.3978/j.issn.2095-6959.2020.01.031 |
[5] |
倪利华. 糖尿病性骨质疏松症的研究进展[J]. 临床与病理杂志, 2020, 40(7):1897-1901. doi: 10.3978/j.issn.2095-6959.2020.07.043 |
[6] |
PASCHOU S Α, DEDE A D, ANAGNOSTIS P G, et al. Type 2 diabetes and osteoporosis: a guide to optimal management[J]. J ClinEndocrinolMetab,2017,102(10):3621-3634. |
[7] |
李弘磊, 杨涛, 范红旗. 2型糖尿病合并骨质疏松的相关因素分析[J]. 中国医药, 2015, 10(5):644-648. doi: 10.3760/cma.j.issn.1673-4777.2015.05.012 |
[8] |
POIANA C. Osteoporosis and fracture risk in patients with type 2 diabetes mellitus[J]. ActaEndo (Buc),2019,15(2):231-236. doi: 10.4183/aeb.2019.231 |
[9] |
易云平, 张思伟, 潘虹. 老年2型糖尿病骨质疏松相关因素分析[J]. 中国骨质疏松杂志, 2017, 23(1):59-61,111. doi: 10.3969/j.issn.1006-7108.2017.01.013 |
[10] |
ARDAWI M S M, AKHBAR D H, ALSHAIKH A, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes[J]. Bone,2013,56(2):355-362. doi: 10.1016/j.bone.2013.06.029 |
[11] |
韩栋, 王奔, 卢晓栋, 等. 中老年2型糖尿病患者发生骨质疏松的影响因素[J]. 中国慢性病预防与控制, 2020, 28(2):149-151. doi: 10.16386/j.cjpccd.issn.1004-6194.2020.02.016 |
[12] |
XU H, WANG Z D, LI X R, et al. Osteoporosis and osteopenia among patients with type 2 diabetes aged ≥50: role of sex and clinical characteristics[J]. J Clin Densitom,2020,23(1):29-36. doi: 10.1016/j.jocd.2019.04.004 |
[13] |
郑倩莲, 徐家林. 唑来膦酸注射液在糖尿病骨质疏松患者中的实施意义[J]. 糖尿病新世界, 2020, 23(16):78-80. doi: 10.16658/j.cnki.1672-4062.2020.16.078 |
[14] |
SCHWARTZ A V. Efficacy of osteoporosis therapies in diabetic patients[J]. Calcif Tissue Int,2017,100(2):165-173. doi: 10.1007/s00223-016-0177-8 |
[15] |
SEALAND R, RAZAVI C, ADLER R A. Diabetes mellitus and osteoporosis[J]. CurrDiabetes Rep,2013,13(3):411-418. |
[16] |
赵蕾, 王立, 鲁梅花, 等. 唑来膦酸与阿仑膦酸钠治疗绝经后骨质疏松症的效果和安全性比较[J]. 中国综合临床, 2017, 33(12):1134-1137. doi: 10.3760/cma.j.issn.1008-6315.2017.12.019 |
[17] |
KURRA S, FINK D A, SIRIS E S. Osteoporosis-associated fracture and diabetes[J]. EndocrinolMetabClinN Am,2014,43(1):233-243. |
[18] |
马远征, 王以朋, 刘强, 等. 中国老年骨质疏松症诊疗指南(2018)[J]. 中国骨质疏松杂志, 2018, 24(12):1541-1567. |
[19] |
孙军平, 徐向阳, 吕刚. 糖尿病性骨质疏松症的治疗进展[J]. 医学综述, 2017, 23(13):2634-2638. doi: 10.3969/j.issn.1006-2084.2017.13.030 |